查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1378847

製药市场：2023-2028 年全球产业趋势、份额、规模、成长、机会与预测

Pharmerging Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028
出版日期: | 出版商: IMARC | 英文 149 Pages | 商品交期: 2-3个工作天内

价格

抽象的

2022年全球医药市场规模达11亿美元。展望未来， IMARC Group预计到2028年市场规模将达到22亿美元，2022-2028年复合年增长率（CAGR）为12.2%。

医药併购是指在医药市场中地位较低但成长较快的一群国家。一些主要的医药市场包括中国、印度、巴西、俄罗斯、南非、墨西哥、印尼、土耳其等。

医疗保健支出的增加以及私立医院数量的增加目前正在推动全球医药市场的成长。此外，多种慢性病的高盛行率以及消费者对早期疾病检测和治疗程序的意识不断增强，进一步促进了市场的成长。此外，老年人口的增加也增加了对药品的需求，他们更容易罹患严重的疾病，如失智症、高血压、心臟衰竭等。此外，各国为降低慢性病治疗成本而推出的政府政策和报销计画也推动了市场的成长。此外，製药国家越来越多的保险公司提供多种保单以减少自付费用，这进一步增加了这些国家的药品需求。除此之外，生物技术、免疫学、肿瘤学等领域广泛研发活动的投资不断增加，以引进先进的治疗方法，也促进了市场的成长。

本报告回答的关键问题：

  • 迄今为止，全球製药市场的表现如何，未来几年将如何表现？
  • 主要区域市场有哪些？
  • COVID-19 对全球医药市场有何影响？
  • 基于产品的市场区隔是什么？
  • 根据指示，市场的细分是什么？
  • 基于配销通路的市场区隔是什么？
  • 产业价值链的各个阶段是什么？
  • 市场的关键驱动因素和挑战是什么？
  • 全球医药市场的结构如何？谁是主要参与者？
  • 市场竞争程度如何？

目录

第一章：前言

第 2 章：范围与方法

  • 研究目的
  • 利害关係人
  • 资料来源
    • 主要资源
    • 二手资料
  • 市场预测
    • 自下而上的方法
    • 自上而下的方法
  • 预测方法

第 3 章：执行摘要

第 4 章：简介

  • 概述
  • 主要行业趋势

第 5 章：全球医药市场

  • 市场概况
  • 市场业绩
  • COVID-19 的影响
  • 市场预测

第 6 章：按产品分類的市场区隔

  • 製药
    • 市场走向
    • 主要类型
      • 专利处方药
      • 非专利处方药
      • 非处方药
    • 市场预测
  • 卫生保健
    • 市场走向
    • 主要类型
      • 医疗设备
      • 临床诊断
      • 其他的
    • 市场预测

第 7 章：按迹象分類的市场

  • 生活方式疾病
    • 市场走向
    • 市场预测
  • 癌症与自体免疫疾病
    • 市场走向
    • 市场预测
  • 传染性疾病
    • 市场走向
    • 市场预测
  • 其他的
    • 市场走向
    • 市场预测

第 8 章：按配销通路分類的市场区隔

  • 医院
    • 市场走向
    • 市场预测
  • 零售药局
    • 市场走向
    • 市场预测
  • 网上商店
    • 市场走向
    • 市场预测
  • 其他的
    • 市场走向
    • 市场预测

第 9 章：按国家/地区分類的市场细分

  • 第一级
    • 中国
      • 市场走向
      • 市场预测
  • 第二级
    • 印度
      • 市场走向
      • 市场预测
    • 巴西
      • 市场走向
      • 市场预测
    • 俄罗斯
      • 市场走向
      • 市场预测
    • 南非
      • 市场走向
      • 市场预测
  • 第三级
    • 阿根廷
      • 市场走向
      • 市场预测
    • 墨西哥
      • 市场走向
      • 市场预测
    • 波兰
      • 市场走向
      • 市场预测
    • 乌克兰
      • 市场走向
      • 市场预测
    • 土耳其
      • 市场走向
      • 市场预测
    • 沙乌地阿拉伯
      • 市场走向
      • 市场预测
    • 埃及
      • 市场走向
      • 市场预测
    • 阿尔及利亚
      • 市场走向
      • 市场预测
    • 奈及利亚
      • 市场走向
      • 市场预测
    • 泰国
      • 市场走向
      • 市场预测
    • 印尼
      • 市场走向
      • 市场预测
    • 巴基斯坦
      • 市场走向
      • 市场预测
    • 其他的
      • 市场走向
      • 市场预测

第 10 章：SWOT 分析

  • 概述
  • 优势
  • 弱点
  • 机会
  • 威胁

第 11 章：价值链分析

第 12 章：波特五力分析

  • 概述
  • 买家的议价能力
  • 供应商的议价能力
  • 竞争程度
  • 新进入者的威胁
  • 替代品的威胁

第13章：竞争格局

  • 市场结构
  • 关键参与者
  • 关键参与者简介
    • Sanofi SA
    • Pfizer Inc.
    • AstraZeneca Plc.
    • GlaxoSmithKline Plc.
    • F. Hoffmann-La Roche AG (Roche AG)
    • Eli Lilly and Company
    • Johnson & Johnson
    • Abbott Laboratories
    • Novartis AG
    • Teva Pharmaceutical Limited
Product Code: SR112023A3441

Abstract

The global pharmerging market size reached US$ 1.1 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 2.2 Billion by 2028, exhibiting a growth rate (CAGR) of 12.2% during 2022-2028.

Pharmerging refers to a group of countries that hold low positioning in the pharmaceutical market but have a speedy growth. Some of the key pharmerging markets include China, India, Brazil, Russia, South Africa, Mexico, Indonesia, Turkey, etc.

The increasing healthcare expenditures along with the rising number of private hospitals are currently propelling the global pharmerging market growth. Additionally, the high prevalence of numerous chronic diseases and growing consumer awareness towards early disease detection and treatment procedures are further augmenting the market growth. Moreover, the increasing geriatric population, who are more prone to serious medical conditions, such as dementia, hypertension, cardiac failure, etc., is also bolstering the demand for pharmaceuticals. Additionally, the introduction of government policies and reimbursement schemes across various countries for reducing the cost of treatment for chronic diseases is also propelling the market growth. Moreover, the growing number of insurance companies in the pharmerging countries offering numerous insurance policies to decrease the out-of-the-pocket expenditures is further augmenting the demand of pharmaceuticals in these countries. Apart from this, the rising investments in extensive R&D activities in the fields of biotechnology, immunology, oncology, etc., for the introduction of advanced treatments are also catalyzing the market growth.

Key Market Segmentation:

IMARC Group provides an analysis of the key trends in each sub-segment of the global pharmerging market report, along with forecasts at the global and country level from 2023-2028. Our report has categorized the market based on product, indication and distribution channel.

Breakup by Product:

Pharmaceuticals

Patented Prescription Drugs

Generic Prescription Drugs

OTC Drugs

Healthcare

Medical Devices

Clinical Diagnosis

Others

Breakup by Indication:

Lifestyle Diseases

Cancer and Autoimmune Diseases

Infectious Diseases

Others

Breakup by Distribution Channel:

Hospitals

Retail Pharmacies

Online Stores

Others

Breakup by Country:

Tier I

China

Tier II

India

Brazil

Russia

South Africa

Tier III

Argentina

Mexico

Poland

Ukraine

Turkey

Saudi Arabia

Egypt

Algeria

Nigeria

Thailand

Indonesia

Pakistan

Others

Competitive Landscape:

The competitive landscape of the industry has also been examined with some of the key players being Sanofi S.A., Pfizer Inc., AstraZeneca Plc, GlaxoSmithKline Plc, F. Hoffmann-La Roche AG (Roche AG), Eli Lilly and Company, Johnson & Johnson, Abbott Laboratories, Novartis AG and Teva Pharmaceutical Limited.

Key Questions Answered in This Report:

  • How has the global pharmerging market performed so far and how will it perform in the coming years?
  • What are the key regional markets?
  • What is the impact of COVID-19 on the global pharmerging market?
  • What is the breakup of the market based on the product?
  • What is the breakup of the market based on the indication?
  • What is the breakup of the market based on the distribution channel?
  • What are the various stages in the value chain of the industry?
  • What are the key driving factors and challenges in the market?
  • What is the structure of the global pharmerging market and who are the key players?
  • What is the degree of competition in the market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Pharmerging Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Product

  • 6.1 Pharmaceutical
    • 6.1.1 Market Trends
    • 6.1.2 Major Types
      • 6.1.2.1 Patented Prescription Drugs
      • 6.1.2.2 Generic Prescription Drugs
      • 6.1.2.3 OTC Drugs
    • 6.1.3 Market Forecast
  • 6.2 Healthcare
    • 6.2.1 Market Trends
    • 6.2.2 Major Types
      • 6.2.2.1 Medical Devices
      • 6.2.2.2 Clinical Diagnosis
      • 6.2.2.3 Others
    • 6.2.3 Market Forecast

7 Market Breakup by Indication

  • 7.1 Lifestyle Diseases
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Cancer and Autoimmune Diseases
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3 Infectious Diseases
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast
  • 7.4 Others
    • 7.4.1 Market Trends
    • 7.4.2 Market Forecast

8 Market Breakup by Distribution Channel

  • 8.1 Hospitals
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Retail Pharmacies
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3 Online Stores
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast
  • 8.4 Others
    • 8.4.1 Market Trends
    • 8.4.2 Market Forecast

9 Market Breakup by Country

  • 9.1 Tier I
    • 9.1.1 China
      • 9.1.1.1 Market Trends
      • 9.1.1.2 Market Forecast
  • 9.2 Tier II
    • 9.2.1 India
      • 9.2.1.1 Market Trends
      • 9.2.1.2 Market Forecast
    • 9.2.2 Brazil
      • 9.2.2.1 Market Trends
      • 9.2.2.2 Market Forecast
    • 9.2.3 Russia
      • 9.2.3.1 Market Trends
      • 9.2.3.2 Market Forecast
    • 9.2.4 South Africa
      • 9.2.4.1 Market Trends
      • 9.2.4.2 Market Forecast
  • 9.3 Tier III
    • 9.3.1 Argentina
      • 9.3.1.1 Market Trends
      • 9.3.1.2 Market Forecast
    • 9.3.2 Mexico
      • 9.3.2.1 Market Trends
      • 9.3.2.2 Market Forecast
    • 9.3.3 Poland
      • 9.3.3.1 Market Trends
      • 9.3.3.2 Market Forecast
    • 9.3.4 Ukraine
      • 9.3.4.1 Market Trends
      • 9.3.4.2 Market Forecast
    • 9.3.5 Turkey
      • 9.3.5.1 Market Trends
      • 9.3.5.2 Market Forecast
    • 9.3.6 Saudi Arabia
      • 9.3.6.1 Market Trends
      • 9.3.6.2 Market Forecast
    • 9.3.7 Egypt
      • 9.3.7.1 Market Trends
      • 9.3.7.2 Market Forecast
    • 9.3.8 Algeria
      • 9.3.8.1 Market Trends
      • 9.3.8.2 Market Forecast
    • 9.3.9 Nigeria
      • 9.3.9.1 Market Trends
      • 9.3.9.2 Market Forecast
    • 9.3.10 Thailand
      • 9.3.10.1 Market Trends
      • 9.3.10.2 Market Forecast
    • 9.3.11 Indonesia
      • 9.3.11.1 Market Trends
      • 9.3.11.2 Market Forecast
    • 9.3.12 Pakistan
      • 9.3.12.1 Market Trends
      • 9.3.12.2 Market Forecast
    • 9.3.13 Others
      • 9.3.13.1 Market Trends
      • 9.3.13.2 Market Forecast

10 SWOT Analysis

  • 10.1 Overview
  • 10.2 Strengths
  • 10.3 Weaknesses
  • 10.4 Opportunities
  • 10.5 Threats

11 Value Chain Analysis

12 Porters Five Forces Analysis

  • 12.1 Overview
  • 12.2 Bargaining Power of Buyers
  • 12.3 Bargaining Power of Suppliers
  • 12.4 Degree of Competition
  • 12.5 Threat of New Entrants
  • 12.6 Threat of Substitutes

13 Competitive Landscape

  • 13.1 Market Structure
  • 13.2 Key Players
  • 13.3 Profiles of Key Players
    • 13.3.1 Sanofi S.A.
      • 13.3.1.1 Company Overview
      • 13.3.1.2 Product Portfolio
      • 13.3.1.3 Financials
      • 13.3.1.4 SWOT Analysis
    • 13.3.2 Pfizer Inc.
      • 13.3.2.1 Company Overview
      • 13.3.2.2 Product Portfolio
      • 13.3.2.3 Financials
      • 13.3.2.4 SWOT Analysis
    • 13.3.3 AstraZeneca Plc.
      • 13.3.3.1 Company Overview
      • 13.3.3.2 Product Portfolio
      • 13.3.3.3 Financials
      • 13.3.3.4 SWOT Analysis
    • 13.3.4 GlaxoSmithKline Plc.
      • 13.3.4.1 Company Overview
      • 13.3.4.2 Product Portfolio
      • 13.3.4.3 Financials
      • 13.3.4.4 SWOT Analysis
    • 13.3.5 F. Hoffmann-La Roche AG (Roche AG)
      • 13.3.5.1 Company Overview
      • 13.3.5.2 Product Portfolio
      • 13.3.5.3 Financials
      • 13.3.5.4 SWOT Analysis
    • 13.3.6 Eli Lilly and Company
      • 13.3.6.1 Company Overview
      • 13.3.6.2 Product Portfolio
      • 13.3.6.3 Financials
      • 13.3.6.4 SWOT Analysis
    • 13.3.7 Johnson & Johnson
      • 13.3.7.1 Company Overview
      • 13.3.7.2 Product Portfolio
      • 13.3.7.3 Financials
      • 13.3.7.4 SWOT Analysis
    • 13.3.8 Abbott Laboratories
      • 13.3.8.1 Company Overview
      • 13.3.8.2 Product Portfolio
      • 13.3.8.3 Financials
      • 13.3.8.4 SWOT Analysis
    • 13.3.9 Novartis AG
      • 13.3.9.1 Company Overview
      • 13.3.9.2 Product Portfolio
      • 13.3.9.3 Financials
      • 13.3.9.4 SWOT Analysis
    • 13.3.10 Teva Pharmaceutical Limited
      • 13.3.10.1 Company Overview
      • 13.3.10.2 Product Portfolio
      • 13.3.10.3 Financial
      • 13.3.10.4 SWOT Analysis

List of Figures

  • Figure 1: Global: Pharmerging Market: Major Drivers and Challenges
  • Figure 2: Global: Pharmerging Market: Sales Value (in Billion US$), 2017-2022
  • Figure 3: Global: Pharmerging Market: Breakup by Product (in %), 2022
  • Figure 4: Global: Pharmerging Market: Breakup by Indication (in %), 2022
  • Figure 5: Global: Pharmerging Market: Breakup by Distribution Channel (in %), 2022
  • Figure 6: Global: Pharmerging Market: Breakup by Country (in %), 2022
  • Figure 7: Global: Pharmerging Market Forecast: Sales Value (in Billion US$), 2023-2028
  • Figure 8: Global: Pharmerging (Pharmaceuticals) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 9: Global: Pharmerging (Pharmaceuticals) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 10: Global: Pharmerging (Healthcare) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 11: Global: Pharmerging (Healthcare) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 12: Global: Pharmerging (Lifestyle Diseases) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 13: Global: Pharmerging (Lifestyle Diseases) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 14: Global: Pharmerging (Cancer and Autoimmune Diseases) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 15: Global: Pharmerging (Cancer and Autoimmune Diseases) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 16: Global: Pharmerging (Infectious Diseases) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 17: Global: Pharmerging (Infectious Diseases) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 18: Global: Pharmerging (Other Indications) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 19: Global: Pharmerging (Other Indications) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 20: Global: Pharmerging (Hospitals) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 21: Global: Pharmerging (Hospitals) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 22: Global: Pharmerging (Retail Pharmacies) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 23: Global: Pharmerging (Retail Pharmacies) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 24: Global: Pharmerging (Online Stores) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 25: Global: Pharmerging (Online Stores) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 26: Global: Pharmerging (Other Distribution Channels) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 27: Global: Pharmerging (Other Distribution Channels) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 28: Tier I: Pharmerging Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 29: Tier I: Pharmerging Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 30: China: Pharmerging Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 31: China: Pharmerging Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 32: Tier II: Pharmerging Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 33: Tier II: Pharmerging Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 34: India: Pharmerging Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 35: India: Pharmerging Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 36: Brazil: Pharmerging Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 37: Brazil: Pharmerging Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 38: Russia: Pharmerging Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 39: Russia: Pharmerging Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 40: South Africa: Pharmerging Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 41: South Africa: Pharmerging Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 42: Tier III: Pharmerging Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 43: Tier III: Pharmerging Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 44: Argentina: Pharmerging Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 45: Argentina: Pharmerging Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 46: Mexico: Pharmerging Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 47: Mexico: Pharmerging Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 48: Poland: Pharmerging Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 49: Poland: Pharmerging Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 50: Ukraine: Pharmerging Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 51: Ukraine: Pharmerging Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 52: Turkey: Pharmerging Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 53: Turkey: Pharmerging Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 54: Saudi Arabia: Pharmerging Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 55: Saudi Arabia: Pharmerging Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 56: Egypt: Pharmerging Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 57: Egypt: Pharmerging Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 58: Algeria: Pharmerging Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 59: Algeria: Pharmerging Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 60: Nigeria: Pharmerging Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 61: Nigeria: Pharmerging Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 62: Thailand: Pharmerging Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 63: Thailand: Pharmerging Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 64: Indonesia: Pharmerging Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 65: Indonesia: Pharmerging Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 66: Pakistan: Pharmerging Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 67: Pakistan: Pharmerging Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 68: Others: Pharmerging Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 69: Others: Pharmerging Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 70: Global: Pharmerging Industry: SWOT Analysis
  • Figure 71: Global: Pharmerging Industry: Value Chain Analysis
  • Figure 72: Global: Pharmerging Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Pharmerging Market: Key Industry Highlights, 2022 and 2028
  • Table 2: Global: Pharmerging Market Forecast: Breakup by Product (in Million US$), 2023-2028
  • Table 3: Global: Pharmerging Market Forecast: Breakup by Indication (in Million US$), 2023-2028
  • Table 4: Global: Pharmerging Market Forecast: Breakup by Distribution Channel (in Million US$), 2023-2028
  • Table 5: Global: Pharmerging Market Forecast: Breakup by Country (in Million US$), 2023-2028
  • Table 6: Global: Pharmerging Market: Competitive Structure
  • Table 7: Global: Pharmerging Market: Key Players